BioSpace News Archive

Encision Inc., a medical device company owning patented Active Electrode Monitoring Technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, announced that Encision has signed a Supplier Agreement with Human Xtensions.

RadNet, Inc. reported financial results for its fourth quarter and full year ended December 31, 2022.

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today issued its financial results for the fourth quarter and the full year ended December 31, 2022.

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that Scott Hutton, Chief Executive Officer of Biodesix, will participate in a fireside chat and host in-person 1x1 investor meetings at Cowen’s 43rd Annual Healthcare Conference being held from March 6-8, 2023.

Theratechnologies Inc. today announced that it has entered into a first amendment to its credit agreement dated July 20, 2022 (the “Credit Facility”) with certain funds and accounts for which Marathon Asset Management, L.P. acts as investment manager (collectively, “Marathon”).

Owens & Minor, Inc. reported financial results for the fourth quarter and the year ended December 31, 2022, as summarized in the table below.

Merck today provided updates on two Phase 3 trials, KEYNOTE-641 and KEYNOTE-789.

Nanoscope Therapeutics Inc. announced that the International Nonproprietary Names Expert Committee of the World Health Organization has selected “sonpiretigene isteparvovec” for the nonproprietary name of the Company’s MCO-010, an ambient-light activatable Multi-Characteristic Opsin optogenetic monotherapy to restore vision in patients with retinitis pigmentosa and Stargardt disease.

Prelude Corporation announced it has entered into a managed care provider agreement with MediNcrease Health Plans, a national provider network in the US, to make accessible the PreludeDx’s DCISionRT® test to its clients and payers.

Covalon Technologies Ltd. has announced that the annual and special meeting of shareholders of the Company will be held on Wednesday, March 8, 2023 at 3:30pm EST.